Hochschulschrift
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
79 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Im Titel sind "90", "177" und "68" hochgestellt
Ludwig-Maximilians-Universität München, Dissertation, 2019
- Schlagwort
-
Hochschulschrift
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:18 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2019
Ähnliche Objekte (12)
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Standardized image quality for 68Ga-DOTA-TATE PET/CT
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
Initial clinical evaluation of indigenous 90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and 90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability,90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects
Personal dose equivalent H p(0.07) during 68Ga-DOTA-TATE production procedures
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Standardized image quality for 68Ga-DOTA-TATE PET/CT
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
Initial clinical evaluation of indigenous 90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and 90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability,90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects
Personal dose equivalent H p(0.07) during 68Ga-DOTA-TATE production procedures
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Standardized image quality for 68Ga-DOTA-TATE PET/CT
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
Initial clinical evaluation of indigenous 90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and 90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability,90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects